Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
The Bill & Melinda Gates Foundation announced the appointment of Indian philanthropist Ashish Dhawan, founder and CEO of Convergence Foundation, to its board of trustees.